Trichosporon species have been reported as emerging pathogens and usually occur in severely immunocompromised patients. In the present work, 27 clinical isolates of Trichosporon species were recovered from 27 patients. The patients were not immunocompromised, except for one with acute myeloid leukemia. Sequence analysis revealed the isolation of Trichosporon dohaense Taj 
Trichosporon species are yeast-like fungi, widely distributed in nature and commonly isolated from soil and other environmental sources, which have been involved in a variety of opportunistic infections and have been recognized as emerging fungal pathogens in immunocompromised hosts (19, 79, 80) . Disseminated Trichosporon infections are potentially lifethreatening and are often fatal in neutropenic patients (7, 22) . Although uncommon, pathogenic species of this genus have been reported increasingly, mostly in patients with malignant diseases (3, 6, 9, 10, 11, 20, 32, 44, 47, 48, 63, 77) , neonates (18, 56, 84) , a bone marrow transplant recipient (22) , a solid organ transplant recipient (50) , and patients with human immunodeficiency virus (34, 35, 46) . Trichosporon has also been reported to cause fungemia (5, 9, 25, 29, 30, 33, 53, 62) . Members of the genus Trichosporon have occasionally been implicated as nail pathogens (16, 28, 74) and in subcutaneous infections (66) . Trichosporon is considered an opportunistic agent, and therefore, recovery of Trichosporon species capable of growing at 37°C, especially from immunocompromised patients, should be regarded as potentially significant. Several reports have addressed the difficulty of identifying Trichosporon to the species level by physiological and biochemical characteristics (2, 64) ; therefore, molecular methods based on the sequencing of the internal transcribed spacer (ITS) have been developed (15, 69, 71, 72) .
In the present paper, we report the isolation of Trichosporon species from clinical specimens over a 4-year period in Qatar, the poor performance of biochemical identification methods, the significance of molecular identification, and the antifungal susceptibility data for the isolates. While investigating the molecular identification of Trichosporon species, we found three strains that do not match any of the published strains in the literature. We describe this organism as Trichosporon dohaense Taj-Aldeen, Meis & Boekhout, sp. nov., the name proposed for this species.
ation of the organism. According to standard laboratory guidelines, total colony counts in the range of 10 4 to 10 5 CFU/ml or more were considered significant, and the presence of yeast cells observed by direct microscopy of urine, with associated clinical symptoms such as pyuria, suggested urinary tract infection. Organisms isolated from specimens that did not meet such criteria were excluded from the study. Trichosporon species isolated from nails were considered significant after two successive isolations from a patient, direct microscopy showing compatible fungal cells, and the absence of dermatophytes in culture, according to the diagnostic criteria of Gupta et al. (26) . Culture plates were incubated at 28°C and 37°C and were observed daily for growth up to 5 days. Colonies appearing yeast-like in consistency were examined in a lactophenol cotton blue wet mount for microscopic characteristics. Trichosporon showed budding yeast cells, hyphae, and arthroconidia.
Biochemical identification. A small inoculum from an isolated colony of each isolate was inoculated onto SDAϩSP plates, incubated at 37°C for 48 h, and used to prepare inocula for substrate assimilation profiles employing the Vitek II yeast identification (ID) system (Biomerieux, France), as recommended by the manufacturer. The yeast suspension was automatically inoculated into a Vitek II ID yeast card, which was programmed to identify only three Trichosporon species, viz., Trichosporon asahii, T. inkin, and T. mucoides. The isolates were also identified using the API ID 32 C system (Biomérieux).
Morphology, physiology, and rRNA gene sequencing. The morphology of the isolates was investigated using line inoculations onto the following media: YPGA (1% yeast extract-0.5% bacteriological peptone L37 [Oxoid]-4% glucose agar), yeast malt extract agar (Difco), yeast morphology agar (YMoA; Difco), malt extract agar (Oxoid), SDA (Difco), and potato dextrose agar (PDA; Difco). The formation of blastoconidia was also investigated using these media. Growth at different temperatures (25, 30, 35, 37, 40 , and 42°C) was evaluated using inoculated YPGA slants placed in incubators at the appropriate temperatures. The nutritional requirements, fermentative capabilities, reactions to diazonium blue B, and urease activities of the yeast strains were assessed according to the work of Yarrow (83) .
Genomic DNA was extracted as described by Bolano et al. (8) , with minor adjustments. Molecular identification of the isolate was performed by sequence analysis of the D1-D2 domains and the ITS1 and ITS2 regions of ribosomal DNA according to the method of Okoli et al. (54) . The sequences generated were compared to the available data in the NCBI database with the Basic Local Alignment Search Tool (BLASTn) (4) . Trees were generated with PAUP (version 4.0b10) using the neighbor-joining algorithm with Kimura 2 as a distance measure and 1,000 bootstrap replicates (75) .
Susceptibility testing. The susceptibilities of all the strains to amphotericin B (Bristol-Myers Squibb, Woerden, The Netherlands), itraconazole (Janssen Research Foundation, Beerse, Belgium), fluconazole, voriconazole, anidulafungin (Pfizer Central Research, Sandwich, United Kingdom), caspofungin (Merck Sharp & Dohme BV, Haarlem, The Netherlands), posaconazole (ScheringPlough, Utrecht, The Netherlands), and isavuconazole (Basilea Pharmaceutica, Basel, Switzerland) were tested using the standard broth microdilution method as described in NCCLS (now CLSI) document M27-A2 (49) .
Each isolate was grown on SDA at 35°C for 24 to 48 h, and a stock inoculum suspension was prepared according to the recommendations of the NCCLS (49). This suspension was then adjusted with a spectrophotometer to 75 to 77% transmittance at a wavelength of 530 nm. The working suspension was made by a 1:1,000 dilution of the suspension in RPMI 1640 (GIBCO BRL, Life Technologies, Woerden, The Netherlands) to produce the final test concentration of 1 ϫ 10 3 to 5 ϫ 10 3 CFU/ml. Aliquots (100 l) of the diluted suspension were inoculated into 96-well flat-bottom microtiter plates (Costar; Omnilabo International BV, Breda, The Netherlands) with antifungals by using a multichannel pipette. The concentrations of amphotericin B, itraconazole, voriconazole, and program at 450 nm. The MIC of amphotericin B was taken from the well with the lowest concentration with 100% inhibition of growth (compared to the growth control well), while the MICs of fluconazole, itraconazole, voriconazole, posaconazole, isavuconazole, caspofungin, and anidulafungin were taken from the wells with prominent decreases in turbidity (approximately Յ50% growth inhibition) from that of the growth control well. Ranges for MICs and for MICs at which 50 and 90% of the isolates of T. asahii tested were inhibited (MIC 50 and MIC 90 ) were calculated. The MICs for the quality control strains Candida parapsilosis ATCC 22019 and Candida krusei ATCC 6258 were all within the reference ranges (data not shown).
Nucleotide sequence accession numbers. The T. dohaense strains identified in this study were assigned the following GenBank accession numbers: FJ228473 for the large subunit (LSU) and FJ228476 for the ITS of the case 14 isolate; FJ228472 for the LSU and FJ228474 for the ITS of the case 17 isolate; and FJ228471 for the LSU and FJ228475 for the ITS of the case 20 isolate.
RESULTS
Twenty-seven isolates of Trichosporon species originating from 27 patients were obtained. Information pertaining to the source of isolation and the clinical symptoms of the patients yielding these isolates is provided in Table 1 . Low discernible differences were observed in the microscopic morphologies of the strains. The assimilation profiles of the strains by the Vitek II and/or the API ID 32 C system were not discriminatory for some strains. When the clinical isolates were subjected to identification by these two biochemical methods, 13 isolates were identified as T. asahii and 1 as T. inkin, while 13 isolates yielded variable results, but the systems were not discriminatory, and hence, these isolates are referred to as "Trichosporon species," indicating the inability of biochemical methods to discriminate among various Trichosporon species. When conventional identification methods were employed, Trichosporon species such as T. japonicum and T. inkin were misidentified as T. asahii, or T. asahii was misidentified as T. inkin (Table 1) .
Molecular identification of the strains yielded 17 T. asahii isolates and 10 isolates of other Trichosporon species: 3 T. inkin, 3 T. dohaense, 2 T. faecale, and 2 T. japonicum isolates. Of the specimens examined, seven were from urine, seven from nails, two from ear discharges, four from superficial sites (three from skin and one from hair), and one each from tissue, bone, urethral discharge, blood, respiratory, balanitis, and a catheter. There were 21 males and 6 females, aged 6 to 77 years (median age, 38.5 years). The apparent bias toward male patients can be explained by the fact that the majority of the immigrant workers in Qatar who form the main patient groups are males. All patients had one or more preexisting clinical manifestations, such as pyuria, onychomycosis, skin infection, fungemia, or a respiratory problem.
Phylogenetically (Fig. 1) (67) . Based on the sequencing analysis, the closest relative to the three strains of T. dohaense is T. coremiiforme, with 97.8% similarity for the ITS and 99.8% similarity for the D1-D2 region. The percentages of similarity and numbers of mismatches with other species in the Ovoides cluster are given in Table 2 . T. inkin can be differentiated by its growth at 42°C; T. caseorum utilizes lysine; and the other species, except for T. lactis, do not assimilate glucosamine, which is slowly and weakly assimilated by T. dohaense. T. dohaense differs from T. lactis by growth on melezitose, starch, methanol, glucosamine (N source), and 0.01% cycloheximide; growth at 37°C; and lack of growth on sorbose, mannitol, lactate, and nitrite (67) . On the basis of these data, we propose the following description of the new species T. dohaense.
Latin description of Trichosporon dohaense Taj the margin. They are butyrous, cream to pale café au lait (isabella), but toward the margin they become whitish, dull to shiny, glabrous, or covered with a whitish aerial mycelium. The margin is entirely or locally submerged with hyphal growth. On SDA, colonies are Candida-like, smooth with a mucoid texture ( Fig. 2A) , and they become irregular to warty in older cultures ( (vi) Clinical origin. T. dohaense was isolated from cutaneous specimens. Strain Myco 483 (CBS 10761 T ) was isolated from a 34-year-old male patient from India with tinea pedis. The patient had irritated, erythematous scaly lesions on the left lower limb (dorsal and plantar) for 4 years. The patient was successfully treated with oral terbinafine tablets, local econazole cream, and Whitfield's ointment (salicylic acid and benzoic acid).
Antifungal susceptibility testing. ity to amphotericin B (MICs, 0.5 to 1 mg/liter) and the azoles posaconazole and isavuconazole. There was one T. asahii isolate for which the fluconazole MIC was 64 mg/liter and the voriconazole MIC was also higher (2 mg/liter). The new azole isavuconazole was the most potent drug, with the lowest MICs for all species. The echinocandins, caspofungin and anidulafungin (both with MICs of Ͼ8 mg/liter), demonstrated no activity against Trichosporon species (not shown).
DISCUSSION
The reported clinical cases caused by opportunistic fungal infections are constantly rising, and new species within the genus Trichosporon are emerging. Cases of Guehomyces pullulans (T. pullulans) (17) infection of patients with chronic granulomatous disease (45) or the isolation of this species from the oral cavities of AIDS patients (52) (67) . T. asahii is isolated mainly from the blood, lung tissue, and urine of patients suffering from deep-seated trichosporonosis (23, 67) , but it is also isolated from skin (23) or white piedra (14, 78) . T. asahii is the most common species, isolated in the present work from a variety of specimens, including urine, nail, skin, tissue, and bone (Table  1) . T. asahii is thought to be much more common in cases of systemic infection than other Trichosporon species (81). Our study supports the view that T. asahii is the most common species associated with human clinical specimens and has a wide geographical distribution (2). Guého et al. (23, 24) significantly revised the taxonomy of the genus Trichosporon on the basis of partial 26S rRNA sequences, combined with a reanalysis of morphological and biochemical properties and an analysis of the coenzyme Q system. The genus Trichosporon was delineated as containing six clearly differentiated opportunistic pathogens of humans (23): T. asahii and T. mucoides are known to cause deep invasive infections; T. asteroides and T. cutaneum cause superficial skin infections; T. ovoides causes white piedra of the scalp; and T. inkin causes white piedra of the pubic hair. Unfortunately, most of the literature on serious opportunistic trichosporonosis refers to the older nomenclature of T. beigelii. Several new taxa have recently been proposed for inclusion in the genus (17, 21, 38, 39, 40-42, 43, 70, 73) . The genus Trichosporon now comprises 36 species. The number of Trichosporon species causing disseminated disease is expanding; T. asteroides, T. loubieri, and T. dermatis have recently been shown to cause disseminated trichosporonosis (25, 33, 38, 55) . Trichosporon has been reported to be the most common cause of nonCandida yeast infections in patients with hematological malignancies, and the infections were associated with high mortality rates, despite antifungal therapy (59) . Accurate identification of Trichosporon species is important, since different species may have different antifungal susceptibilities (57, 59, 64) ; T. asahii, T. faecale, and T. coremiiforme exhibited high MICs for amphotericin B, while other species showed lower MICs (64, 65) . For most of the Trichosporon isolates in our study, high amphotericin B MICs were found, confirming previous results. Although echinocandins are increasingly regarded as the preferred treatment choice for candidemia in patients with severe sepsis and septic shock (58) , clinical failure and breakthrough infections with Trichosporon have been reported with the use of caspofungin and micafungin (3, 7) . In this study, caspofungin and anidulafungin demonstrated no in vitro activity against Trichosporon species. The general conclusion is that polyenes and echinocandins should not be used to treat Trichosporon infections. The five azoles tested in our series were all active in vitro, confirming previous reports on voriconazole and itraconazole (64) . Only one T. asahii isolate exhibited a fluconazole MIC of 64 mg/liter, with a simultaneous increase in the voriconazole MIC (2 mg/liter). In general, itraconazole, voriconazole, posaconazole, and isavuconazole are active against Trichosporon species in vitro, with the most potent agent being the new azole isavuconazole. The assimilation of a large number of carbon and nitrogen compounds traditionally forms the basis for the species identification of yeasts, although the inconsistency of assimilation may cause misleading identification results. The Vitek II and API ID 32 C systems are programmed to identify only three species of Trichosporon, namely, T. asahii, T. inkin, and T. mucoides. Consequently, strains may be misidentified, and genetically distinct species could be overlooked ( Table 1 ). The application of modern molecular methods, including the sequencing of rRNA genes, offers a reliable means of overcoming this difficulty (17, 43, 64) .
T. inkin is frequently isolated from clinical specimens (66), such as white piedra (13, 23, 76) , but also from patients with peritonitis (12, 36, 37) , endocarditis (61), lung abscesses (60), subcutaneous nodules (rheumatoid arthritis patients receiving corticosteroid therapy) (65), sternal surgical wound infections (13) , and invasive infections (31, 82) . In the present study, T. inkin was isolated in cases of white piedra, balanitis, and urethral discharge. T. asteroides is known to have been isolated from skin (2, 23) and from a patient with a nosocomial bloodstream infection (33) . T. ovoides is not reported to cause systemic infections but is known to cause white piedra (14) , and the species is isolated from the homes of patients with summertype hypersensitivity pneumonitis (67, 68, 72) . The isolation of Trichosporon species from various clinical specimens in the present work further suggests that the species-specific patterns of infection previously delineated in Trichosporon infection (23) need reconsideration.
Although T. coremiiforme, T. faecale, and T. japonicum have been isolated from the houses of patients with summer-type hypersensitivity pneumonitis (64, 67, 68) , they have occasionally been isolated from clinical specimens. More recently, T. faecale was isolated from the skin of a tinea pedis patient (27) , and T. japonicum was isolated from a sputum specimen (1) . During this study, T. japonicum was isolated in two cases of tinea pedis. T. faecale was isolated from two patients: a 32-year old male patient with pyuria and a 6-year old female patient with fungemia (Table 1) . To our knowledge, this report describes the first case of fungemia caused by T. faecale, which was successfully treated with liposomal amphotericin B (5.8 mg/kg of body weight/day) for 2 weeks. The present study reports the emergence of T. japonicum and T. faecale as potent human pathogens.
The new species, T. dohaense was isolated three times from cutaneous sites (tinea pedis, onychomycosis, and an infected catheter site) during the past 4 years in Doha, Qatar. The emergence of T. dohaense as a human pathogen supports the idea that Trichosporon species are potent opportunistic human pathogens, and therefore, the recovery of a Trichosporon species from a clinical specimen should be regarded as potentially significant. Moreover, the currently available Vitek II yeast identification and API ID 32 C systems are not reliable enough to identify correctly all the clinically relevant Trichosporon species, and molecular analysis is required to achieve an accurate identification of the species.
